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Abstract
Struma ovarii is a rare form of ovary tumour defined as the 
presence of ectopic thyroid tissue in the ovarian structures. It 
usually presents with a benign course, although in some cases 
carcinoma or other malignant tumours can be found in the con-
text of the ectopic tissue. Herein we report the case of a young 
patient affected by struma ovarii visualized by means of 124I-Na 
PET/CT. Thanks to the excellent target-to-background ratio of 
the tracer and the high resolution of the method, we could well 
identify the presence of some minimal tumour at the level of the 
left ovary. To our knowledge, this is the first report of its kind.
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Struma ovarii is a rare form of ovary tumour, accounting for 1% 
of the ovarian neoplasia, and deﬁ ned as the presence of ectopic 
thyroid tissue in the ovarian structures [1]. It usually presents with 
a benign course, although in some cases carcinoma or other malig-
nant tumours can be found in the context of the ectopic tissue [2, 3]. 
Herein we report the case of a young patient affected by struma 
ovarii, which was incidentally diagnosed during a caesarean deli-
very. Our 29 year-old patient had the removal of an ovarian cyst dur-
ing the delivery and histology showed a well-differentiated papillary 
carcinoma of thyroid origin. Speciﬁ c investigations of the thyroid 
gland, including ultrasound, made the possibility of malignant 
transformation of the eutopic tissue unlikely, thus suggesting that 
the degeneration found in the struma ovarii had an in-loco origin 
(non-metastatic). Before undergoing further treatment [4, 5], we de-
cided to perform a total-body PET/CT scan with 124I-Na (Figure 1). 
Thanks to the excellent target-to-background ratio of the tracer and 
Figure 1. Maximal Intensity Projection (MIP) image of 124I-Na PET/CT 
and fused coronal, sagittal and axial sections, showing the ectopic 
tissue present in the left ovary (arrow); for the study the patient 
received an I.V. injection of 212 MBq (5.7 mCi) of 124I-Na, and 
images were acquired 24 hours later (T1/2 4.2days) by means of a 3D 
PET/CT tomograph (Siemens Biograph 6 LSO: 3.5 min/bed position, 
128 × 128 matrix, zoom 1.0, 95 mAs, 130 kV and 5 mm collimation 
6 × 3 mm for the localization CT; OSEM iterative algorithm).
Along with the pathologic tracer accumulation, we could also identify 
some physiologic uptake in the thyroid gland, as well as in the 
stomach and in the bladder, due to salivary and urinary excretion
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the high resolution of the method (~0.5 cm), we could well identify 
the presence of some minimal tumour residue (diameter = 0.6 cm; 
ki67 ~25%) at the level of the left ovary (arrow). This could not be 
imaginable with other methods, including total-body 123/131I-Na 
scan, because of the suboptimal resolution (1.0–1.5 cm) or CT/MR, 
because of the inadequate speciﬁ city.
To our knowledge, this is the ﬁ rst report of its kind, document-
ing the presence of struma ovarii by means of 124I-Na PET/CT.
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